Short answer
DENTSPLY SIRONA Inc (XRAY) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $836M (down 7.5% year over year) with net income of −$2M.
Q3 2026 key financials · XBRL
- Revenue
- $836M
- −7.5% YoY · −6.9% QoQ
- Net income
- −$2M
- +99.5% YoY · −105.4% QoQ
- Operating margin
- 4.4%
- Gross margin
- 53.0%
- EPS (diluted)
- −$0.02
- +99.1% YoY · −110.5% QoQ
Source: XBRL data from the DENTSPLY SIRONA Inc (XRAY) Q3 2026 10-Q on SEC EDGAR. USD.
DENTSPLY SIRONA Inc Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 net sales down 5.2% YoY; segment revenue amounts not visible in provided table
- Gross margin 52.9% vs 48.8% YoY; SG&A margin 43.4% vs 39.4%
- Wellspect best segment, sales up 4.1% constant currency; OIS worst, down 7.2%
- Operating cash flow increased, aided by $47M tariff refunds and lower receivables
- Outlook: $165M-$185M 2026 capex; macro, tariffs, inflation and distributor inventory headwinds
Risk Factors
- No material changes from the 2025 Form 10-K risk factors
- Carried-forward risks include regulatory, operational, competitive, market, and financial exposures disclosed in the 2025 Form 10-K
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.